Abstract
Katherine L Webb, Raj C Shah, Lawrence Beilin, alice owen, Michelle A Fravel, Robyn L Woods, Mark R Nelson, Kevan R Polkinghorne, Nigel Stocks, Rory Wolfe, Jordana B. Cohen, Christopher M Reid
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Systolic blood pressure time in target range and cardiovascular outcomes in patients with hypertension
10.1016/j.jacc.2021.01.014 · 2021
Blood pressure and its variability: classic and novel measurement techniques
10.1038/s41569-022-00690-0 · 2022
Time in therapeutic range, as a determinant of all-cause mortality in patients with hypertension
10.1161/jaha.117.007131 · 2017
Blood pressure time at target and its prognostic value for cardiovascular outcomes: a scoping review
10.1038/s41440-024-01798-1 · 2024
Time in target range for blood pressure and adverse health outcomes: a systematic review
10.1161/hypertensionaha.124.24013 · 2025
Effect of aspirin on cardiovascular events and bleeding in the healthy elderly
10.1056/nejmoa1805819 · 2018
Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial
10.1093/eurheartj/ehaf514 · 2025
Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial
10.1016/j.cct.2013.09.014 · 2013
Health characteristics and aspirin use in participants at the baseline of the ASPirin in Reducing Events in the Elderly - eXTension (ASPREE-XT) observational study
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
10.1016/j.cct.2023.107231 · 2023
Recommendations for blood pressure measurement in humans and experimental animals, part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council
10.1161/01.hyp.0000150859.47929.8e · 2005
A method to determine the optimal intensity of oral anticoagulant therapy
10.1055/s-0038-1651587 · 1993
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
10.1016/s0140-6736(02)11911-8 · 2002
The effect of low-dose aspirin on frailty phenotype and frailty index in community-dwelling older adults in the ASPirin in Reducing Events in the Elderly Study
10.1093/gerona/glab340 · 2022
Blood pressure time in target range and its impact on clinical outcomes
10.1007/s11886-024-02111-9 · 2024
Systolic blood pressure time in target range and major adverse kidney and cardiovascular events
10.1161/hypertensionaha.122.20141 · 2023
Systolic blood pressure time in target range and incident atrial fibrillation in patients with hypertension: insights from the SPRINT trial
10.1161/hypertensionaha.123.21651 · 2023
Systolic blood pressure time in target range and acute kidney injury in patients with hypertension
10.1161/hypertensionaha.125.25511 · 2025
Systolic blood pressure time in target range and cognitive outcomes: insights from the SPRINT MIND trial
10.1161/hypertensionaha.122.20711 · 2023
Sustained blood pressure control and coronary heart disease, stroke, heart failure, and mortality: an observational analysis of ALLHAT
10.1111/jch.13515 · 2019
Association of systolic blood pressure time in target range with cardiovascular events among PRECISION participants
10.1111/jch.70009 · 2025
Time spent at blood pressure target and the risk of death and cardiovascular diseases
10.1371/journal.pone.0202359 · 2018
Association of long-term time in target range for systolic blood pressure with cardiovascular risk in the elderly: a Chinese veteran cohort study
10.1093/eurjpc/zwad083 · 2023
Optimizing blood pressure targets in patients with cardiovascular disease: rethinking control in terms of time in range
2026
No additional external references are available.